Angina and Myocardial infarction Flashcards
Ischaemic heart disease
Reduced blood supply to the heart due to insufficiency of the coronary arteries
Angina
Poor oxygen supply to myocardium> chest pains
Types of agina
- Stable: D>S- predictable chest pains on exertion/ mental distress
- Unstable: S>D- pains occur with less exertion
- Variant: S>D- Occurs at rest
Acute coronary syndrome
heart’s blood supply is partially/ fully blocked> myocardial damage
- Includes unstable angina and myocardial infarction
Stable angina pharmacotherapy drugs
Vasodilators
- Organic nitrates
- Beta-blockers
- CCB
Decrease cardiac work
- BB & CCB
Underlying atheromatous diseases
- Statins & aspirin
Organic nitrate drugs and their MOA
- Glyceryl trinitrate, Isosorbide dinitrate, Isosorbide mononitrate
- Pro-drug that is metabolized to NO> NO activates guanyl cyclase to produce cGMP> cGMP dephosphorylates myosin and sequester Ca2+> vasoldilation
Nitrate-free window in evening
- Thiol depleted by long-acting nitrates. Not taking in the evening allows thiol to accumulate> may potentiate ischeamia due to period of no therapeutic efficacy
Organic nitrate contraindications and side effects
- 5- phosphdiesterase inhibitors> severe hypotension
- Hypotension, Headaches, reflex tachycardia
MOA of statins
- Inhibits HMG-CoA reductase mediated conversion of HMG-CoA to mevalonate in liver.
- Mevalonate needed to produce cholesterl> decrease hepatic cholesterol> increases LDL-C clearance from plasma
Statin drugs
Lipophilic
- Simvastatin(SA): pro-drug
- Atorvastatin(LA)
Hydrophilic
- Rosuvastatin(LA)
- Pravastatin(LA)
Statin side effects
- myalgia
- GI disturbances
- Insomnia
- Angio-oedema
Aims for unstable angina pharmacotherapy
- Revascularation
- Prevent re-occlusion
- Decrease cardiac work
- Prevent cardiac remodeling
- treat associated pain
Unstable angia pharmacotherapy drugs
Low risk patients:
- Aspirin
- Organic nitrates, BB, CCB
Intermediate risk
- Aspirin, LMWH/UH
- Organic nitrates, BB, CCB
High risk
- ‘…’ and Clopidogrel
- Organic nitrates, BB, CCB
- Abciximab (for revascularisation)
Pharmacotherapy for STEMI
- Oxygen if saturation below 94%
- Aspirin
- Organic nitrates, morphine
- Fibrinolytics
Oygen supplementation adverse effacts that are frequent in normoxic patients
- Hyperoxemia
- Reduced coronary blood flow
- Free radical generation
- increase coronary vascular resistency